Good Samaritan Society - Bloomfield | |
300 North Second St, Bloomfield, Nebraska 68718 | |
(402) 373-2531 | |
Name | Good Samaritan Society - Bloomfield |
---|---|
Location | 300 North Second St, Bloomfield, Nebraska |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 70 |
Occupancy Rate | 41% |
Medicare ID (CCN) | 285156 |
Legal Business Name | The Evangelical Lutheran Good Samaritan Society |
Ownership Type | Non Profit - Corporation |
NPI Number | 1932181336 |
Organization Name | THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY |
Doing Business As | GOOD SAMARITAN SOCIETY - BLOOMFIELD |
Address | 300 N 2nd St, Bloomfield, NE 68718 |
Phone Number | 402-373-2531 |
News Archive
The odds of measuring an elevated blood pressure can vary by as much as 40 percent depending on the time of day and time of year, according to researchers from the Center for Health Research and Rural Advocacy at Geisinger Health System in Pennsylvania. They recommend that clinicians anticipate changes in blood pressure due to these temporal factors when diagnosing and considering treatment options for their patients.
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
Researchers in the United States have shown that Moderna's mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine induces durable antibody and T cell responses to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are comparable to those seen in cases of COVID-19 caused by natural SARS-CoV-2 infection.
Stem cells persist in the adult mammalian brain and generate new neurons throughout life. A research group at the Biozentrum of the University of Basel reports in the current issue of "Science" that long-distance brain connections can target discrete pools of stem cells in their niche and stimulate them to divide and produce specific subtypes of olfactory bulb neurons
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The odds of measuring an elevated blood pressure can vary by as much as 40 percent depending on the time of day and time of year, according to researchers from the Center for Health Research and Rural Advocacy at Geisinger Health System in Pennsylvania. They recommend that clinicians anticipate changes in blood pressure due to these temporal factors when diagnosing and considering treatment options for their patients.
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
Researchers in the United States have shown that Moderna's mRNA-1273 coronavirus disease 2019 (COVID-19) vaccine induces durable antibody and T cell responses to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are comparable to those seen in cases of COVID-19 caused by natural SARS-CoV-2 infection.
Stem cells persist in the adult mammalian brain and generate new neurons throughout life. A research group at the Biozentrum of the University of Basel reports in the current issue of "Science" that long-distance brain connections can target discrete pools of stem cells in their niche and stimulate them to divide and produce specific subtypes of olfactory bulb neurons
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 1 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.75 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.06 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.25 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.6 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.56 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.62 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 12.88 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.16 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.93 | 83.88 |